Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Regulated Protein Degradation02:58

Regulated Protein Degradation

7.6K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.6K
The Proteasome01:13

The Proteasome

1.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.1K
GPCR Desensitization01:12

GPCR Desensitization

6.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.4K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

105.6K
Overview
105.6K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Tetanus mimicking post-radiotherapy dysphagia in a head and neck cancer survivor:A case report with institutional review.

Auris, nasus, larynx·2026
Same author

Head-to-Head Comparison of Monomeric, Homodimeric, and Heterodimeric Fibroblast Activation Protein-Targeting Radioligands Based on Small Molecule Inhibitor and Cyclic Peptide.

ACS pharmacology & translational science·2026
Same author

Structure-Guided Grafting of Cell-Penetrating Motifs into Stapled Peptides for Intracellular PPI Inhibition.

Journal of medicinal chemistry·2026
Same author

The effect of preanalytical factors on cerebrospinal fluid and plasma proteomics: a systematic experimental study.

Clinical proteomics·2026
Same author

Longitudinal Changes in Patient-Reported Outcomes Following Carpal Tunnel Release: A Retrospective Cohort Study.

The Journal of hand surgery·2026
Same author

Correction to "Linker and Conjugation Site Synergy in Antibody-Drug Conjugates: Impacts on Biological Activity".

Bioconjugate chemistry·2026

関連する実験動画

Updated: Sep 9, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

10.1K

還元的に活性化されたCPP-PROTACナノコンプレックスは,効率的な細胞吸収によって標的の分解を強化する.

Maho Miyamoto1,2, Kosuke Saito3, Hidetomo Yokoo2

  • 1Graduate School of Medical Life Science, Yokohama City University 1-7-29 Yokohama 230-0045 Japan.

RSC chemical biology
|September 2, 2025
PubMed
まとめ

細胞に浸透するペプチド-PROTAC結合体 (MZ1-R9) と デクストラン硫酸塩を用いて ナノ粒子を作りました この投与システムは,PROTACの生物利用性を向上させ,細胞膜の課題を克服します.

さらに関連する動画

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.3K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.6K

関連する実験動画

Last Updated: Sep 9, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

10.1K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.3K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.6K

科学分野:

  • バイオテクノロジー
  • 分子生物学
  • 薬物投与システム

背景:

  • 標的型タンパク質分解は 有望な治療戦略です
  • 従来のタンパク質分解標的キメラ (PROTAC) は,細胞の吸収と生物利用性に問題があります.
  • 効果的な投与システムを開発することは,PROTACの有効性にとって極めて重要です.

研究 の 目的:

  • PROTACのための新しいナノ粒子配送プラットフォームを開発する.
  • 細胞の吸収とBRD4分解の効率を高めるために,PROTAC結合剤を使用します.
  • PROTACの生物利用性を改善し,膜の透過性の障壁を克服する.

主な方法:

  • 細胞に浸透するペプチド (R9) とPROTAC (MZ1) の結合は,ディスルファイドリンクナーによって行われます.
  • デクストラン硫酸ナノ粒子の中にMZ1-R9結合体を封じ込む.
  • 標的細胞における細胞吸収とBRD4分解の評価

主要な成果:

  • MZ1- R9ナノ粒子は,フリーなPROTACと比較して,細胞吸収が強化されたことを示した.
  • ナノ粒子で治療された細胞では,著しいBRD4分解が観察されました.
  • PROTACの生物利用性と有効性は,ナノ粒子投与システムによって改善されました.

結論:

  • 開発されたナノ粒子プラットフォームは PROTAC を細胞に効果的に送ります.
  • この戦略は,膜の透過性の問題を克服することによって,標的型タンパク質の分解を強化します.
  • MZ1-R9のナノ粒子ベースの投与は,標的型タンパク質の分解における治療的応用にとって有望である.